Compared to T1DM patients, WS patients show lower daily insulin requirements, lower average HbA1c levels, lower incidence of diabetic ketoacidosis and microvascular complications, and higher incidence of severe hypoglycemia [42, 43]. This evidence concerns the gene INS and type 2 diabetes mellitus.